common.study.topics.clinical

DCE MRI in Patients with Pancreatic Cancer

common.study.values.description

DCE MRI in Patients With Pancreatic Cancer

This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who have undergone chemotherapy for pancreatic cancer.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Undergo DCE MRI

Drug - Ferumoxytol

Given IV

participant.views.study.view.additional

participant.views.study.view.scientific-title

The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer

common.study.values.clinical-trial-id

NCT02070705

participant.views.study.view.id

0dN0Ka